Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2008

Open Access 01-12-2008 | Research

Conceptual adequacy of the neuropathic pain symptom inventory in six countries

Authors: Bruce Crawford, Didier Bouhassira, Audrey Wong, Ellen Dukes

Published in: Health and Quality of Life Outcomes | Issue 1/2008

Login to get access

Abstract

Background

Neuropathic pain results from a nerve lesion or nerve damage. Because it is a subjective experience, patient-reported outcomes may measure both the symptoms and impact on the patient's life. The purpose of this study was to determine whether the Neuropathic Pain Symptom Inventory (NPSI) adequately assesses neuropathic pain symptoms in patients with diabetic peripheral neuropathy, post-herpetic neuralgia, trigeminal neuralgia, and sciatica across multiple cultures.

Methods

From data collected from 132 subjects in 6 countries, qualitative research methods identified their most important symptoms (and verbal descriptions) associated with neuropathic pain. A core set of commonly described symptoms spanning multiple cultures was also described. Moderators using a semi-structured discussion guide conducted focus groups consisting of patients in the U.S., Brazil, Japan, China, Finland, and Spain to elicit concepts that were most important and relevant (concept elicitation phase). Study subjects ranked the importance of each neuropathic pain symptom, completed the NPSI, and commented on its ability to capture key symptoms (face and content validation phase).

Results

Descriptive terms for sensations of neuropathic pain were similar in all countries; burning, electric shocks, and pins and needles were among the most-common sensations. Individuals with neuropathic pain experienced all sensations that were included in the NPSI. They also tended to describe pins and needles and numbness interchangeably, perhaps reflecting the relative number of DPN subjects on study.

Conclusion

Based on data from these focus groups, the NPSI is an acceptable instrument for assessing neuropathic pain.
Literature
1.
go back to reference Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. Eur J Pharmacol 2001, 429: 1–11. 10.1016/S0014-2999(01)01302-4CrossRefPubMed Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. Eur J Pharmacol 2001, 429: 1–11. 10.1016/S0014-2999(01)01302-4CrossRefPubMed
2.
go back to reference Hansson P: Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain 2002, 6: 47–50. 10.1053/eujp.2001.0322CrossRefPubMed Hansson P: Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain 2002, 6: 47–50. 10.1053/eujp.2001.0322CrossRefPubMed
3.
go back to reference Merskey H, Bogduk N: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd edition. Seattle: IASP Press; 1994. Merskey H, Bogduk N: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd edition. Seattle: IASP Press; 1994.
4.
go back to reference Backonja M: Defining neuropathic pain. Anesth Analg 2003, 97: 785–790. 10.1213/01.ANE.0000062826.70846.8DCrossRefPubMed Backonja M: Defining neuropathic pain. Anesth Analg 2003, 97: 785–790. 10.1213/01.ANE.0000062826.70846.8DCrossRefPubMed
5.
go back to reference Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpää M, Jørum E, Serra J, Jensen TS: EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004, 11: 153–162. 10.1111/j.1468-1331.2004.00791.xCrossRefPubMed Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpää M, Jørum E, Serra J, Jensen TS: EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004, 11: 153–162. 10.1111/j.1468-1331.2004.00791.xCrossRefPubMed
6.
go back to reference Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48(2):332–338.CrossRefPubMed Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48(2):332–338.CrossRefPubMed
7.
go back to reference Krause SJ, Backonja MM: Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19: 306–314. 10.1097/00002508-200309000-00004CrossRefPubMed Krause SJ, Backonja MM: Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19: 306–314. 10.1097/00002508-200309000-00004CrossRefPubMed
8.
go back to reference Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F: Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004, 108(3):248–257. 10.1016/j.pain.2003.12.024CrossRefPubMed Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F: Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004, 108(3):248–257. 10.1016/j.pain.2003.12.024CrossRefPubMed
9.
go back to reference Bastyr E, Price K, Bril V, the MBBQ Study Group: Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics 2005, 27(8):1278–94. 10.1016/j.clinthera.2005.08.002CrossRefPubMed Bastyr E, Price K, Bril V, the MBBQ Study Group: Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clinical Therapeutics 2005, 27(8):1278–94. 10.1016/j.clinthera.2005.08.002CrossRefPubMed
10.
go back to reference US Department of Health and Human Services: Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Food and Drug Administration 2006. US Department of Health and Human Services: Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Food and Drug Administration 2006.
11.
go back to reference EMEA: Reflection Paper On The Regulatory Guidance For The Use Of Health Related Quality Of Life (HRQL): Measures In The Evaluation Of Medicinal Products. 2005. EMEA: Reflection Paper On The Regulatory Guidance For The Use Of Health Related Quality Of Life (HRQL): Measures In The Evaluation Of Medicinal Products. 2005.
12.
go back to reference Portenoy R: Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006, 22(8):1555–1565. 10.1185/030079906X115702CrossRefPubMed Portenoy R: Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006, 22(8):1555–1565. 10.1185/030079906X115702CrossRefPubMed
13.
go back to reference Charmaz K: Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. Thousand Oaks, CA: SAGE Pu; 2006. Charmaz K: Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. Thousand Oaks, CA: SAGE Pu; 2006.
Metadata
Title
Conceptual adequacy of the neuropathic pain symptom inventory in six countries
Authors
Bruce Crawford
Didier Bouhassira
Audrey Wong
Ellen Dukes
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2008
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-6-62

Other articles of this Issue 1/2008

Health and Quality of Life Outcomes 1/2008 Go to the issue